☆ 4.7 Article

Effectiveness of Inactivated COVID-19 Vaccines Against Illness Caused by the B.1.617.2 (Delta) Variant During an Outbreak in Guangdong, China A Cohort Study

ANNALS OF INTERNAL MEDICINE (2022)

Related references

Note: Only part of the references are listed.

Review Biochemistry & Molecular Biology

COVID-19 vaccines: where we stand and challenges ahead

Guido Forni et al.

Summary: The development of vaccines has made significant progress, but still faces various challenges, including different target populations, immunological adaptability of vaccines, and production and distribution issues. To ensure equitable access, protection of diverse subjects, and immunity against viral variants, multiple vaccines may be needed in the long run.

CELL DEATH AND DIFFERENTIATION (2021)

Add to Collection

Editorial Material Infectious Diseases

Optimism and caution for an inactivated COVID-19 vaccine

Christina A. Rostad et al.

LANCET INFECTIOUS DISEASES (2021)

Add to Collection

Article Multidisciplinary Sciences

China COVID vaccine reports mixed results — what does that mean for the pandemic?

Smriti Mallapaty

NATURE (2021)

Add to Collection

Editorial Material Immunology

Critical aspects of packaging, storage, preparation, and administration of mRNA and adenovirus-vectored COVID-19 vaccines for optimal efficacy

Gregory A. Poland

VACCINE (2021)

Add to Collection

Article Economics

Anticipation of COVID-19 vaccines reduces willingness to socially distance

Ola Andersson et al.

Summary: The anticipation and positive information of COVID-19 vaccines can reduce voluntary social distancing and adherence to public health guidelines, ultimately accelerating the spread of infectious diseases. As vaccination rolls out, policies aimed at increasing social distancing may become less effective, and stricter policies might be needed.

JOURNAL OF HEALTH ECONOMICS (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Risk Compensation and COVID-19 Vaccines

Brit Trogen et al.

ANNALS OF INTERNAL MEDICINE (2021)

Add to Collection

News Item Multidisciplinary Sciences

CHINA'S COVID VACCINES HAVE BEEN CRUCIAL - NOW IMMUNITY IS WANING

Smriti Mallapaty

NATURE (2021)

Add to Collection

Letter Medicine, General & Internal

Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents

Ben Y. Reis et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Noa Dagan et al.

Summary: A study conducted in Israel on nearly 600,000 individuals showed that the BNT162b2 mRNA vaccine was effective in reducing the risk of infection, hospitalization, and severe Covid-19. The effectiveness in preventing death was 72% during the period from day 14 through day 20 after the first dose, and hospitalization was reduced by 87% for the period 7 or more days after the second dose, similar to results from a randomized trial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Immunology

Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel

Melanie D. Swift et al.

Summary: In a large cohort of US healthcare personnel without prior COVID-19 infection, 94,382 doses of mRNA vaccines were administered to 49,220 individuals, with an adjusted vaccine effectiveness exceeding 96% following 2 doses of mRNA vaccine.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Editorial Material Critical Care Medicine

Waning immunity to SARS-CoV-2: implications for vaccine booster strategies

Daniel M. Altmann et al.

LANCET RESPIRATORY MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

Eric J. Haas et al.

Summary: This study assessed the real-world effectiveness of the Pfizer-BioNTech mRNA COVID-19 vaccine BNT162b2 in Israel, showing high efficacy in preventing SARS-CoV-2 infections, hospitalizations, severe disease, and death. As vaccine coverage increased, there were marked declines in SARS-CoV-2 outcomes, indicating that COVID-19 vaccination can help control the pandemic.

LANCET (2021)

Add to Collection

Article Infectious Diseases

Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study

Sam Moore et al.

Summary: The study found that vaccination alone is insufficient to contain the outbreak. Even with an optimistic assumption that the vaccine can prevent 85% of infections, the reproduction number (R) is estimated to be 1.58 once all eligible adults have been offered both doses of the vaccine without non-pharmaceutical interventions (NPIs).

LANCET INFECTIOUS DISEASES (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Covid-19: What do we know about Sputnik V and other Russian vaccines?

Chris Baraniuk

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Editorial Material Medicine, General & Internal

What do we know about China's covid-19 vaccines?

Chris Baraniuk

Summary: The country where covid-19 first emerged is leading the way in promoting a series of vaccines domestically and internationally. However, lack of transparency around the data leads to a fragmented picture.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Editorial Material Medicine, General & Internal

What do we know about India's Covaxin vaccine?

Kamala Thiagarajan

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel-33 US Sites, January-March 2021

Tamara Pilishvili et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection

Article Medicine, General & Internal

Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults A Randomized Clinical Trial

Nawal Al Kaabi et al.

Summary: This interim analysis of an ongoing randomized trial in the UAE and Bahrain evaluated the efficacy of two inactivated COVID-19 vaccines in preventing symptomatic cases and adverse events in healthy adults. The study found that both vaccines significantly reduced the risk of symptomatic COVID-19 compared to the control group, with efficacy rates of 72.8% and 78.1%. Serious adverse events were rare across all groups.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Medicine, General & Internal

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile

Alejandro Jara et al.

Summary: A study in Chile involving 10.2 million participants assessed the effectiveness of an inactivated SARS-CoV-2 vaccine developed in China. Fully immunized individuals had vaccine effectiveness of 65.9% for preventing Covid-19 and 87.5% for preventing hospitalization, 90.3% for preventing ICU admission, and 86.3% for preventing death.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

Mark G. Thompson et al.

Summary: The study demonstrated that COVID-19 mRNA vaccines were highly effective in preventing SARS-CoV-2 infection in real-world conditions, while also attenuating the viral RNA load, febrile symptoms, and illness duration among vaccinated individuals who had breakthrough infections.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Environmental Sciences

Estimating Relative Risk When Observing Zero Events-Frequentist Inference and Bayesian Credibility Intervals

Soeren Moeller et al.

Summary: This paper compares and discusses different statistical approaches to obtaining CIs for RRs when no events are observed in one of the comparison groups. Most suggested methods can be used effectively, but those based on deliberate, probabilistic considerations are preferable. Bayesian approaches can also be utilized to obtain credibility intervals in such situations.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020–August 2021

Ashley Fowlkes et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection

Article Medicine, General & Internal

Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China

Yaping Wang et al.

Summary: Infection with the Delta variant of concern (VOC) is characterized by a shorter incubation period, higher viral load, and longer duration of viral shedding, with an increased risk of critical illness for patients over the age of 60, calling for more intensive prevention and control measures.

ECLINICALMEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Preparing for COVID-19 exit strategies

Michelle Griffin et al.

Summary: The COVID-19 pandemic has had a significant global impact, leading to lockdowns in many countries to control the virus. As countries work on safe exit strategies, factors such as social distancing, testing capacity, and healthcare system protection need to be considered to prevent ongoing community transmission.

ANNALS OF MEDICINE AND SURGERY (2021)

Add to Collection

Article Medicine, General & Internal

Feasibility of Using Real-World Data to Replicate Clinical Trial Evidence

Victoria L. Bartlett et al.

JAMA NETWORK OPEN (2019)

Add to Collection

Article Public, Environmental & Occupational Health

Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making

Marc L. Berger et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)

Add to Collection

Article Medicine, General & Internal

Sensitivity Analysis in Observational Research: Introducing the E-Value

Tyler J. VanderWeele et al.

ANNALS OF INTERNAL MEDICINE (2017)

Add to Collection

Article Social Sciences, Mathematical Methods

Computing adjusted risk ratios and risk differences in Stata

Edward C. Norton et al.

STATA JOURNAL (2013)

Add to Collection

Article Health Care Sciences & Services

What's the Risk? A Simple Approach for Estimating Adjusted Risk Measures from Nonlinear Models Including Logistic Regression

Lawrence C. Kleinman et al.

HEALTH SERVICES RESEARCH (2009)

Add to Collection

Article Social Sciences, Mathematical Methods

Methods for estimating adjusted risk ratios

Peter Cummings

STATA JOURNAL (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.